Participated · Seed · Apr 2021

Getlabs operates an at-home phlebotomy service that sends trained, W-2 phlebotomists to patients’ homes to collect blood samples, which are processed by partners including Labcorp, Quest Diagnostics and Sonora Quest. The company charges an out-of-pocket “convenience fee” starting at $25 for in-home draws. Founded in 2018 by Kyle Michelson, Getlabs aims to be the in-person arm of telehealth, offering an API to integrate lab scheduling directly into virtual visits. Since its seed round the startup has hired over 100 phlebotomists, reports turnover below 0.5%, and expanded coverage to serve roughly 45% of the U.S. population (up from about 6% four months prior), with a target of 60% by year-end. The business is focused on scaling its workforce and forming partnerships with telehealth companies to enable hybrid care models and broader clinical testing access. Getlabs provides at-home blood draws by dispatching phlebotomists to patients and sending samples to partner labs such as Labcorp and Quest Diagnostics. The company charges patients a $29–$49 fee for home draws while insurance covers the lab processing as usual. Getlabs raised a $3 million seed round to fund expansion and has run soft launches in Phoenix, Philadelphia, and Dallas. Founder and CEO Kyle Michelson started the company after experiencing the inconvenience of in-person lab draws during Y Combinator. The fully remote company has 37 employees and plans to expand into other home-health verticals. Getlabs aims to integrate with telemedicine providers so patients can receive more care at home and notes that roughly 70% of medical decisions are based on lab results while about 30% of patients skip lab orders due to inconvenience.